Pathophysiology and treatment of cranial dystonia

Movement Disorders

Volumn 17, Issue SUPPL. 2, 2002, Pages

  Berardelli, Alfredo ^a,b   Curra, Antonio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Botulinum toxin; Brainstem; Cranial dystonia; Neurophysiology

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; OLANZAPINE; TETRABENAZINE; TRIHEXYPHENIDYL;

ARTICLE; BLEPHAROSPASM; BRAIN FUNCTION; BRAIN STEM RESPONSE; CLINICAL FEATURE; DIPLOPIA; DOPAMINERGIC ACTIVITY; DROWSINESS; DRUG EFFICACY; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAM; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; EYELID REFLEX; FACIAL NERVE PARALYSIS; HUMAN; JAW OPENING REFLEX; MOTOR CORTEX; MUSCLE CONTRACTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PTOSIS; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT PLANNING;

ANIMALS; BLEPHAROSPASM; BLINKING; BRAIN STEM; CRANIOMANDIBULAR DISORDERS; DISEASE MODELS, ANIMAL; DYSTONIA; HUMANS; REFLEX;

EID: 0036930055     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10063     Document Type: Article

References (15)

1. Aramideh M, Ongerboer de Visser BW, Koelman JHTM, Bour LJ, Speelman JD. Electromyography features of levator palpebrae and orbicularis oculi muscles in blepharospasm, Brain 1994;117:27-38.
2. Aramideh M, Eekhof JLA, Bour LJ, Koelman JHTM, Speelman JD, Ongerboer de Visser BW. Electromyography and recovery of the blink reflex in involuntary eyelid closure: a comparative study. J Neurol Neurosurg Psychiatry 1995;58:692-698.
3. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998;121:1195-1212.
4. Valls-Solè J, Tolosa ES, Ribera G. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psychiatry 1991;54: 310-313.
5. Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 1996; 11:27-31.
6. Pauletti G, Berardelli AN, Cruccu G, Agostino R, Manfredi M. Blink reflex and the masseter inhibitory reflex in patients with dystonia. Mov Disord 1993;8:495-500.
7. 18F]spiperone binding in putamen in idiopathic focal dystonia, J Neurosci 1997; 17:843-850.
8. Hutchinson M, Nakamura T, Moeller JR, Antonini A, Belakhlef A, Dhawan V, Eidelberg D. The metabolic topography of essential blepharospasm: a focal dystonia with general implications. Neurology 2000;55:673-677.
9. Feiwell RJ, Black KJ, McGee-Minnich LA, Snyder AZ, MacLeod AM, Perlmutter JS. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm. Neurology 1999;52:291-297.
10. Curra A, Romaniello A, Berardelli A, Cruccu G, Manfredi M. Shortened cortical silent period in facial muscles of patients with cranial dystonia. Neurology 2000;54:130-135.
11. Gomez-Wong E, Marti MJ, Cossu G, Fabregat N, Tolosa ES, Valls-Sole J. The 'geste antagonistique' induces transient modulation of the blink reflex in human patients with blepharospasm. Neurosci Lett 1998;25:125-128.
12. Schrag A, Bhatia KP, Quinn NP, Marsden CD. Atypical and typical cranial dystonia following dental procedures. Mov Disord 1999;14:492-496
13. Chuke JC, Baker RS, Porter JD. Bell's Palsy-associate blepharospasm relieved by aiding eyelid closure. Ann Neurol 1996;39:263-268.
14. Schicatano EJ, Basso MA, Evinger C. Animal model explains the origins of the cranial dystonia benign essential blepharospasm. J Neurophysiol 1997;77:2842-2846.
15. Berardelli A, Abbruzzese G, Bertolasi L, Cantarella G, Carella F, Curra A, De Grandis D, DeFazio G, Galardi G, Gilanda P, Livrea P. Modugno N, Priori A, Ruoppolo G, Vacca L, Manfredi M. Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci 1997;18:261-269.